"We've really worked at understanding the cells that we are engineering in a different way from any other center .... It's allowed us to treat patients with extremely small doses of cells," he said.
When asked by Biden why that matters, Riddell explained: "It's relevant because it makes the process of generating a cell product faster and more cheaply," ultimately making it more affordable and accessible for patients.
Every time Riddell sees patients in the clinic, he goes back to his research with a new sense of urgency, he said. “The courage of patients is inspiring, and it makes me realize that we don’t have the best [treatments] yet. We have to do better.”
This year alone, 600,000 people in the U.S. will die of cancer, noted Gilliland in his welcoming remarks to Biden. “At Fred Hutch, our goal is to cure cancer, not just treat it.”
Read the full article here: https://www.fredhutch.org/en/news/center-news/2016/03/Vice-President-Joe-Biden-visits-Fred-Hutch.html
Vice President Joe Biden talks to cancer immunotherapy researchers Dr. Stan Riddell, left, and Dr. Phil Greenberg during a Fred Hutch lab tour.
Photo by Robert Hood / Fred Hutch News Service